{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T09:01:14Z","timestamp":1784624474988,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Direcci\u00f3n General de Asuntos de Personal Ac\u00e1demico, Universidad Nacional Aut\u00f3noma de M\u00e9xico","award":["UNAM-PAPITT-IA205922 and UNAM-PAPITT-IA206124"],"award-info":[{"award-number":["UNAM-PAPITT-IA205922 and UNAM-PAPITT-IA206124"]}]},{"name":"CONACYT","award":["number 2019-301133"],"award-info":[{"award-number":["number 2019-301133"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"DOI":"10.1007\/s12602-026-11139-y","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T08:03:26Z","timestamp":1784621006000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Antimicrobial Peptide, Dermaseptin DMS-DA6, a Promising Alternative to Conventional Antibiotic in the Treatment of N. brasiliensis-Induced Actinomycetoma"],"prefix":"10.1007","author":[{"given":"Diana Ivonne","family":"Duarte-Mata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Velia","family":"V\u00e1zquez-Marmolejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefania","family":"Alem\u00e1n-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Piesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Rosenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance","family":"Auvynet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Cesar","family":"Salinas-Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"11139_CR1","doi-asserted-by":"publisher","unstructured":"Bonifaz A, Flores P, Sa\u00fal A, Carrasco-Gerard E, Ponce RM (2007) Treatment of actinomycetoma due to Nocardia spp. with amoxicillin?clavulanate. Br J Dermatol 156(2): 308\u2013311.\u00a0https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07557.x","DOI":"10.1111\/j.1365-2133.2006.07557.x"},{"key":"11139_CR2","doi-asserted-by":"publisher","unstructured":"Welsh O, Salinas-Carmona MC, la Garza J-D, Rodriguez-Escamilla IM, Sanchez-Meza E (2018) Current treatment of mycetoma. Curr Treat Options Infect Dis 10(3):389\u2013396. https:\/\/doi.org\/10.1007\/s40506-018-0171-y","DOI":"10.1007\/s40506-018-0171-y"},{"issue":"7","key":"11139_CR3","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1128\/IAI.06307-11","volume":"80","author":"AG Rosas-Taraco","year":"2012","unstructured":"Rosas-Taraco AG, Perez-Li\u00f1an AR, Bocanegra-Ibarias P, Perez-Rivera LI, Salinas-Carmona MC (2012) Nocardia brasiliensis induces an immunosuppressive microenvironment that favors chronic infection in BALB\/c mice. Infect Immun 80(7):2493\u20132499. https:\/\/doi.org\/10.1128\/IAI.06307-11","journal-title":"Infect Immun"},{"key":"11139_CR4","doi-asserted-by":"publisher","unstructured":"Meester I, Rosas-Taraco AG, Salinas-Carmona MC (2014) Nocardia brasiliensis induces formation of foamy macrophages and dendritic cells in vitro and in vivo. PLoS ONE 9(6):e100064. https:\/\/doi.org\/10.1371\/journal.pone.0100064","DOI":"10.1371\/journal.pone.0100064"},{"issue":"4","key":"11139_CR5","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.clindermatol.2011.06.027","volume":"30","author":"O Welsh","year":"2012","unstructured":"Welsh O, Vera-Cabrera L, Welsh E, Salinas MC (2012) Actinomycetoma and advances in its treatment. Clin Dermatol 30(4):372\u2013381. https:\/\/doi.org\/10.1016\/j.clindermatol.2011.06.027","journal-title":"Clin Dermatol"},{"issue":"4","key":"11139_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa090","volume":"7","author":"N Davidson","year":"2020","unstructured":"Davidson N, Grigg MJ, Mcguinness SL, Baird RJ, Anstey NM (2020) Safety and outcomes of linezolid use for nocardiosis. Open Forum Infect Dis 7(4):ofaa090. https:\/\/doi.org\/10.1093\/ofid\/ofaa090","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"11139_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1086\/345907","volume":"36","author":"EH Moylett","year":"2003","unstructured":"Moylett EH et al (2003) Clinical experience with linezolid for the treatment of nocardia infection. Clin Infect Dis 36(3):313\u2013318. https:\/\/doi.org\/10.1086\/345907","journal-title":"Clin Infect Dis"},{"issue":"1","key":"11139_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1586\/edm.09.67","volume":"5","author":"AH Fahal","year":"2010","unstructured":"Fahal AH (2010) Management of mycetoma. Expert Rev Dermatol 5(1):87\u201393. https:\/\/doi.org\/10.1586\/edm.09.67","journal-title":"Expert Rev Dermatol"},{"issue":"20","key":"11139_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222011172","volume":"22","author":"M Drayton","year":"2021","unstructured":"Drayton M et al (2021) Host defense peptides: dual antimicrobial and immunomodulatory action. Int J Mol Sci 22(20):11172. https:\/\/doi.org\/10.3390\/ijms222011172","journal-title":"Int J Mol Sci"},{"issue":"1","key":"11139_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12364-6","volume":"10","author":"R Spohn","year":"2019","unstructured":"Spohn R et al (2019) Integrated evolutionary analysis reveals antimicrobial peptides with limited resistance. Nat Commun 10(1):4538. https:\/\/doi.org\/10.1038\/s41467-019-12364-6","journal-title":"Nat Commun"},{"issue":"12","key":"11139_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22122071","volume":"22","author":"J Pantic","year":"2071","unstructured":"Pantic J, Jovanovic I, Radosavljevic G, Arsenijevic N, Conlon J, Lukic M (2071) The potential of frog skin-derived peptides for development into therapeutically-valuable immunomodulatory agents. Molecules 22(12):2071. https:\/\/doi.org\/10.3390\/molecules22122071","journal-title":"Molecules"},{"key":"11139_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01421","volume":"10","author":"EJH Bartels","year":"2019","unstructured":"Bartels EJH, Dekker D, Amiche M (2019) Dermaseptins, multifunctional antimicrobial peptides: a review of their pharmacology, effectivity, mechanism of action, and possible future directions. Front Pharmacol 10:1421. https:\/\/doi.org\/10.3389\/fphar.2019.01421","journal-title":"Front Pharmacol"},{"issue":"10","key":"11139_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205727","volume":"13","author":"S Cardon","year":"2018","unstructured":"Cardon S et al (2018) Peptidoglycan potentiates the membrane disrupting effect of the carboxyamidated form of DMS-DA6, a Gram-positive selective antimicrobial peptide isolated from Pachymedusa dacnicolor skin. PLoS One 13(10):e0205727. https:\/\/doi.org\/10.1371\/journal.pone.0205727","journal-title":"PLoS One"},{"issue":"12","key":"11139_CR14","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1128\/AAC.45.12.3629-3630.2001","volume":"45","author":"L Vera-Cabrera","year":"2001","unstructured":"Vera-Cabrera L, G\u00f3mez-Flores A, Escalante-Fuentes WG, Welsh O (2001) In vitro activity of PNU-100766 (Linezolid), a new oxazolidinone antimicrobial, against Nocardia brasiliensis. Antimicrob Agents Chemother 45(12):3629\u20133630. https:\/\/doi.org\/10.1128\/AAC.45.12.3629-3630.2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"11139_CR15","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1128\/IAI.67.5.2428-2432.1999","volume":"67","author":"MC Salinas-Carmona","year":"1999","unstructured":"Salinas-Carmona MC, Torres-Lopez E, Ramos AI, Licon-Trillo A, Gonzalez-Spencer D (1999) Immune response to Nocardia brasiliensis antigens in an experimental model of actinomycetoma in BALB\/c mice. Infect Immun 67(5):2428\u20132432","journal-title":"Infect Immun"},{"issue":"12","key":"11139_CR16","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.4049\/jimmunol.2400033","volume":"213","author":"K Steffy","year":"2024","unstructured":"Steffy K, Ahmed A, Srivastava S, Mukhopadhyay S (2024) An insight into the role of IL-10 and foamy macrophages in infectious diseases. J Immunol 213(12):1729\u20131737. https:\/\/doi.org\/10.4049\/jimmunol.2400033","journal-title":"J Immunol"},{"key":"11139_CR17","doi-asserted-by":"publisher","unstructured":"van der Does AM, Hiemstra PS, Mookherjee N (2019) Antimicrobial Host Defence Peptides: Immunomodulatory Functions and Translational Prospects, in Antimicrobial Peptides 1117, K. Matsuzaki, Ed., in Advances in Experimental Medicine and Biology 1117., Singapore: Springer Singapore 149\u2013171. https:\/\/doi.org\/10.1007\/978-981-13-3588-4_10","DOI":"10.1007\/978-981-13-3588-4_10"},{"key":"11139_CR18","doi-asserted-by":"publisher","unstructured":"Ageitos L, Torres MDT,\u00a0De La Fuente-Nunez C (2022) Biologically Active Peptides from Venoms: Applications in Antibiotic Resistance, Cancer, and Beyond. Int J Mol Sci 23(23):15437. https:\/\/doi.org\/10.3390\/ijms232315437.\u00a0","DOI":"10.3390\/ijms232315437"},{"key":"11139_CR19","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.2147\/DDDT.S164515","volume":"Volume 12","author":"SM Hashemian","year":"2018","unstructured":"Hashemian SM, Farhadi T, Ganjparvar M (2018) Linezolid: a review of its properties, function, and use in critical care. Drug Des Devel Ther Volume 12:1759\u20131767. https:\/\/doi.org\/10.2147\/DDDT.S164515","journal-title":"Drug Des Devel Ther"},{"key":"11139_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.peptides.2015.03.028","volume":"71","author":"JM Pantic","year":"2015","unstructured":"Pantic JM, Radosavljevic GD, Jovanovic IP, Arsenijevic NN, Conlon JM, Lukic ML (2015) In vivo administration of the frog skin peptide frenatin 2.1S induces immunostimulatory phenotypes of mouse mononuclear cells. Peptides 71:269\u2013275. https:\/\/doi.org\/10.1016\/j.peptides.2015.03.028","journal-title":"Peptides"},{"issue":"9","key":"11139_CR21","doi-asserted-by":"publisher","first-page":"7487","DOI":"10.1021\/acs.jmedchem.4c00342","volume":"67","author":"Y He","year":"2024","unstructured":"He Y et al (2024) A nonbactericidal anionic antimicrobial peptide provides prophylactic and therapeutic efficacies against bacterial infections in mice by immunomodulatory\u2013antithrombotic duality. J Med Chem 67(9):7487\u20137503. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c00342","journal-title":"J Med Chem"},{"issue":"11","key":"11139_CR22","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1021\/acsinfecdis.3c00316","volume":"9","author":"Y He","year":"2023","unstructured":"He Y et al (2023) Tree frog-derived cathelicidin protects mice against bacterial infection through its antimicrobial and anti-inflammatory activities and regulatory effect on phagocytes. ACS Infect Dis 9(11):2252\u20132268. https:\/\/doi.org\/10.1021\/acsinfecdis.3c00316","journal-title":"ACS Infect Dis"},{"issue":"6","key":"11139_CR23","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.4049\/jimmunol.180.6.4090","volume":"180","author":"CF Anderson","year":"2008","unstructured":"Anderson CF, Lira R, Kamhawi S, Belkaid Y, Wynn TA, Sacks D (2008) IL-10 and TGF-\u03b2 control the establishment of persistent and transmissible infections produced by Leishmania tropica in C57BL\/6 mice. J Immunol 180(6):4090\u20134097. https:\/\/doi.org\/10.4049\/jimmunol.180.6.4090","journal-title":"J Immunol"},{"issue":"7","key":"11139_CR24","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1128\/IAI.73.7.3903-3911.2005","volume":"73","author":"HW Murray","year":"2005","unstructured":"Murray HW et al (2005) Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis. Infect Immun 73(7):3903\u20133911. https:\/\/doi.org\/10.1128\/IAI.73.7.3903-3911.2005","journal-title":"Infect Immun"},{"key":"11139_CR25","doi-asserted-by":"publisher","unstructured":"Liu W et al (2023) Intracellular behavior of Nocardia seriolae and its apoptotic effect on RAW264.7 macrophages. Front Cell Infect Microbiol 13:1138422. https:\/\/doi.org\/10.3389\/fcimb.2023.1138422","DOI":"10.3389\/fcimb.2023.1138422"},{"key":"11139_CR26","doi-asserted-by":"publisher","unstructured":"Chaves RX (2017) Antileishmanial and Immunomodulatory Effects of Dermaseptin-01, A Promising Ppetide against Leishmania amazonensis. Curr Bioact Compd 13. https:\/\/doi.org\/10.2174\/1573407212666161014131415","DOI":"10.2174\/1573407212666161014131415"},{"key":"11139_CR27","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.72849","volume":"11","author":"Y Yang","year":"2022","unstructured":"Yang Y et al (2022) A non-bactericidal cathelicidin provides prophylactic efficacy against bacterial infection by driving phagocyte influx. eLife 11:e72849. https:\/\/doi.org\/10.7554\/eLife.72849","journal-title":"eLife"},{"issue":"162","key":"11139_CR28","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0093-2021","volume":"30","author":"A Sauer","year":"2021","unstructured":"Sauer A, Peukert K, Putensen C, Bode C (2021) Antibiotics as immunomodulators: a potential pharmacologic approach for ARDS treatment. Eur Respir Rev 30(162):210093. https:\/\/doi.org\/10.1183\/16000617.0093-2021","journal-title":"Eur Respir Rev"},{"key":"11139_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01389","volume":"10","author":"J Wang","year":"2019","unstructured":"Wang J, Xia L, Wang R, Cai Y (2019) Linezolid and its immunomodulatory effect: in vitro and in vivo evidence. Front Pharmacol 10:1389. https:\/\/doi.org\/10.3389\/fphar.2019.01389","journal-title":"Front Pharmacol"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-11139-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-026-11139-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-11139-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T08:03:28Z","timestamp":1784621008000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-026-11139-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":29,"alternative-id":["11139"],"URL":"https:\/\/doi.org\/10.1007\/s12602-026-11139-y","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The research complies with all relevant federal guidelines and institutional policies.","order":1,"name":"Ethics","label":"Research involving animals","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}